Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07287176 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System
A NA study of Thyroid Nodule and Ablation, sponsored by Pulse Biosciences.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT07287176: Recruiting NA study of Thyroid Nodule and Ablation, sponsored by Pulse Biosciences.
NCT07287176 is a NA study of Thyroid Nodule and Ablation that is actively recruiting participants, run by Pulse Biosciences. The registered enrollment target is 100 participants, above the 64-participant average among 5 other Thyroid Nodule trials with a reported enrollment target (56% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07287176, a NA study of Thyroid Nodule and Ablation, is actively recruiting participants, sponsored by Pulse Biosciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this study is to reproduce in a multi-center study results obtained during the feasibility First-In-Human (FIH) study with Prof. Stefano Spiezia, MD (Ospedale del Mare, Naples, Italy) and to monitor additional thyroid-related symptoms and impact of patients quality of life post-ablation using a validated QoL questionnaire.
Primary Outcome
The percentage decrease of thyroid nodule volume measured by ultrasonography after treatment (ablation) using the nPulse Vybrance Percutaneous Electrode System
Conditions Studied
Interventions
- DEVICE nPulse Vybrance Percutaneous Electrode System
Study Locations (2)
Florida
- Sarasota Memorial Hospital - Sarasota
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-08-21 |
| Est. Completion | 2027-02 |
| Phase | NA |
What NCT07287176 shows while recruiting
NCT07287176 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 64-participant average among 5 other Thyroid Nodule trials with a reported enrollment target (56% higher).
The record links to 3 conditions, with Thyroid Nodule appearing as the primary indexed condition, and to 1 intervention - of which nPulse Vybrance Percutaneous Electrode System is the first listed.
NCT07287176 reports a single indexed study location in Florida, New York.
Frequently Asked Questions
What is clinical trial NCT07287176 about?
NCT07287176 is a clinical study titled "Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System". The primary objective of this study is to reproduce in a multi-center study results obtained during the feasibility First-In-Human (FIH) study with Prof. Stefano Spiezia, MD (Ospedale del Mare, Naples, Italy) and to monitor additional thyroid-related symptoms and impact of patients quality of life p...
What is the current status of trial NCT07287176?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-08-21. Estimated completion is 2027-02.
What conditions does trial NCT07287176 study?
This clinical trial studies the following conditions: Thyroid Nodule, Ablation, Thyroid Goiter.
What interventions are being tested in trial NCT07287176?
The interventions under investigation include: nPulse Vybrance Percutaneous Electrode System (DEVICE).
Who is sponsoring clinical trial NCT07287176?
This trial is sponsored by Pulse Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07287176 being conducted?
This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Nodule
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Radiofrequency Ablation Study in LatinX Patients
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging Methods
RECRUITING · NA
-
TRAIL Study: Feasibility and Pilot
RECRUITING · NA
-
Decision Aid and Thyroid Nodules Management
RECRUITING · NA
-
Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI